BridgeBio Pharma (BBIO) Other Working Capital Changes (2018 - 2026)
BridgeBio Pharma recorded quarterly Other Working Capital Changes of -$2.4 million in Q1 2026, up 64.34% quarter-over-quarter from -$6.7 million in Q4 2025, and up 7.47% year-over-year from -$2.2 million in Q1 2025.
BridgeBio Pharma's Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 7.47% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$11.2 million (down 138.05% YoY), while the FY2025 annual figure was -$11.4 million, down 152.24% from the prior year.
- Other Working Capital Changes came in at -$2.4 million for Q1 2026 at BridgeBio Pharma, up from -$6.7 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $26.3 million in Q4 2024 to a low of -$27.0 million in Q2 2024.
- A 5-year average of $266176.5 and a median of -$1.8 million in 2022 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 578.26% in 2024 and fell as far as 351.21% in 2024.
- BridgeBio Pharma's Other Working Capital Changes stood at $3.8 million in 2022, then jumped by 86.13% to $7.2 million in 2023, then surged by 267.49% to $26.3 million in 2024, then tumbled by 125.33% to -$6.7 million in 2025, then surged by 64.34% to -$2.4 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$2.4 million, -$6.7 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.38 Mn |
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | -6.67 Mn |
| Dec 31, 2025 | -6.67 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | -3.92 Mn |
| Jun 30, 2025 | -3.92 Mn |
| Mar 31, 2025 | -2.57 Mn |
| Mar 31, 2025 | -2.57 Mn |
| Dec 31, 2024 | 26.33 Mn |
| Dec 31, 2024 | 26.33 Mn |
| Sep 30, 2024 | -1.48 Mn |
| Sep 30, 2024 | -1.48 Mn |
| Jun 30, 2024 | -27.01 Mn |
| Jun 30, 2024 | -27.01 Mn |
| Mar 31, 2024 | 24.02 Mn |
| Mar 31, 2024 | 24.02 Mn |
| Dec 31, 2023 | 7.17 Mn |
| Dec 31, 2023 | 7.17 Mn |
| Sep 30, 2023 | -2.02 Mn |
| Sep 30, 2023 | -2.02 Mn |
| Jun 30, 2023 | -5.99 Mn |
| Jun 30, 2023 | -5.99 Mn |
| Mar 31, 2023 | 3.54 Mn |
| Mar 31, 2023 | 3.54 Mn |
| Dec 31, 2022 | 3.85 Mn |
| Dec 31, 2022 | 3.85 Mn |
| Sep 30, 2022 | -26.74 Mn |
| Sep 30, 2022 | -26.74 Mn |
| Jun 30, 2022 | 18.46 Mn |
| Jun 30, 2022 | 18.46 Mn |
| Mar 31, 2022 | -1.82 Mn |
| Mar 31, 2022 | -1.82 Mn |
| Dec 31, 2021 | -15.05 Mn |
| Dec 31, 2021 | -15.05 Mn |
| Sep 30, 2021 | 11.71 Mn |
| Sep 30, 2021 | 11.71 Mn |
| Jun 30, 2021 | -8.89 Mn |
| Jun 30, 2021 | -8.89 Mn |
| Mar 31, 2021 | 6.11 Mn |
| Mar 31, 2021 | 6.11 Mn |
| Dec 31, 2020 | 1.67 Mn |
| Dec 31, 2020 | 1.67 Mn |
| Sep 30, 2020 | 7.03 Mn |
| Sep 30, 2020 | 7.03 Mn |
| Jun 30, 2020 | -2.37 Mn |
| Jun 30, 2020 | -2.37 Mn |
| Mar 31, 2020 | 734,000.00 |
| Mar 31, 2020 | 734,000.00 |
| Dec 31, 2019 | 8.98 Mn |
| Dec 31, 2019 | 8.98 Mn |
| Sep 30, 2019 | -1.68 Mn |
| Sep 30, 2019 | -1.68 Mn |
| Jun 30, 2019 | 1.49 Mn |
| Jun 30, 2019 | 1.49 Mn |
| Mar 31, 2019 | 1.85 Mn |
| Mar 31, 2019 | 1.85 Mn |
| Dec 31, 2018 | 972,000.00 |
| Dec 31, 2018 | 972,000.00 |
| Sep 30, 2018 | 4,000.00 |
| Sep 30, 2018 | 4,000.00 |